V. Heilmann

1.1k citations
33 papers · 914 · h-index 15

Impact in

Papers in

    • Cancer Treatment and Pharmacology 8
    • HER2/EGFR in Cancer Research 3
    • Cancer-related Molecular Pathways 2
    • Breast Cancer Treatment Studies 7

V. Heilmann

30 papers receiving 886 citations

Peers

V. Heilmann
Comparison fields: 5 of 63
  • Obstetrics and Gynecology 89
  • Oncology 282
  • Cancer Research 134
  • Radiology, Nuclear Medicine and Imaging 169
  • Immunology and Allergy 42
Replace Fumitaka Numa with:
Fumitaka Numa Japan
Harry Klip Netherlands
Renata Tassi Italy
Teresa Drudis Italy
Mischa Houtkamp Netherlands
Isabelle Vanden Bempt Belgium
Frank Priou France
Astrid Hirschmann Germany
Michael Varello United States
Steve Gyorffy Canada
V. Heilmann relative to Fumitaka Numa Japan Fumitaka Numa's profile →
Citations per field
00.5×4.6×
Fumitaka Numa · 1×
Citations per year

Countries citing papers authored by V. Heilmann

Since Specialization
Citations

This map shows the geographic impact of V. Heilmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Heilmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Heilmann more than expected).

Fields of papers citing papers by V. Heilmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Heilmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Heilmann. The network helps show where V. Heilmann may publish in the future.

Co-authors

The 25 scholars most cited alongside V. Heilmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V. Heilmann Line = papers co-authored together V. Heilmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2002177
2 2001146
3 2002125
4 200560
5 200652
6
Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion.
200348
7 200846
8 200541
9 200529
10 200826
11 200623
12 201523
13 201321
14 199421
15 200414
16 200513
17
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes.
200611
18 19996
19 20055
20 20015

About V. Heilmann

V. Heilmann is a scholar working on Oncology, Cancer Research, Epidemiology, Molecular Biology and Obstetrics and Gynecology, having authored 33 papers that have together received 914 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (7 papers), Cervical Cancer and HPV Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Molecular Biology Techniques and Applications (3 papers), Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Obstetrics and Gynecology (89 citations), Oncology (282 citations), Cancer Research (134 citations), Radiology, Nuclear Medicine and Imaging (169 citations) and Immunology and Allergy (42 citations). V. Heilmann has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include R. Kreienberg, Thorsten Kühn, Andreas Gabelmann, Hans‐Juergen Brambs, A. Rieber, Magnus von Knebel Doeberitz, Peter Melsheimer, Matthias Nees, Matthias Dürst and Ruediger Klaes. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Cancer Research and Clinical Oncology, Annals of Oncology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact